Financials
- Market Capitalization 3.03 B
- Employee 507
- Founded 2013
- CEO N/A
- Website www.denalitherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG008P7F869
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-5.56
Fiyat/satışlar oranı
—
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 1627 | RCUS Arcus Biosciences, Inc. Common Stock | 24.34 USD | -0.33% | -1.62% | -1.38% | +48.60% | 3.10 B USD | ||
| 1642 | AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 27.48 USD | -2.35% | -1.75% | -13.69% | +95.59% | 3.06 B USD | ||
| 1663 | ELVN Enliven Therapeutics, Inc. - Common Stock | 40.84 USD | -0.34% | -10.00% | -25.75% | +97.68% | 2.99 B USD | ||
| 1667 | DYN Dyne Therapeutics, Inc. - Common Stock | 15.96 USD | -4.09% | +2.97% | -13.26% | -31.82% | 2.98 B USD |